Search MedEsthetics

83 Results

Type: News

Section: News

Regenerative Medicine Market

Increased Funding Driving Development of Regenerative Medicine

Government and private funding is predicted to help the global regenerative medicine market expand by CAGR of 11.27% by 2027.

Screenshot 2022 01 14 163902

Suneva and Viveon Health Create Regenerative Aesthetics Company

Suneva Medical and Viveon Health Acquisition Corp, a special purpose acquisition company (SPAC), have entered into a definitive merger agreement to create a regenerative aesthetic medicine company.

Corinthia London Launches Partnership to Provide Regenerative Treatments & Education

Corinthia London Launches Partnership to Provide Regenerative Treatments & Education

The London Regenerative Institute was founded with the vision of bringing together the world’s very best regenerative medicine practitioners and therapies to Corinthia London.

Young woman touching her breast implant before surgery.

3 Ways Regenerative Medicine Is Impacting Breast Augmentation [Survey Results]

86% of readers would like to learn how regenerative medicine is impacting breast implants and augmentation! Here are three ways regenerative medicine is transforming breast augmentations.

Revitalize Your Skin with Laser-Cut Serum: 3D Rendering of Vitamin Skin Repair Concept for Saggy Skin Cells. Stock Illustration.

4 Advantages of Offering Regenerative Aesthetic Treatments [Survey Results]

65% of readers said they are currently offering regenerative treatments (PRP, exosome therapies, etc.) at their medspa or practice! Here are four advantages of offering your patients regenerative treatments.

Adobe Stock 846154258

Acne, Regenerative Aesthetics & Individualized Treatments Top the Trends at SCALE 2024

Our third SCALE 2024 trend highlight explores the advances in acne therapy, regenerative aesthetics and individualization making waves at this year's meeting.

The implant is designed to degrade over time, while promoting natural tissue regeneration and integration with host tissue.

CollPlant Launches Porcine Study for 3D Bioprinted Regenerative Breast Implants

The bioprinted regenerative implants aim to overcome the challenges of existing breast procedures that utilize silicone implants and autologous fat transfer.

[Treatment Release] The One-Hour Incisionless Facelift

The One-Hour Incisionless Facelift Uses the Power of Regenerative Medicine with Stem Cell/Exosome and Coolaser Technology

The 60 minute facelift that incorporates its patented Coolaser technology and stem cell/exosome technology. The procedure is based in regenerative medicine and is normally followed by one week of downtime.

LifeSprout's Dermal Filler Achieves Primary Endpoint in Clinical Trial

LifeSprout's Regenerative Matrix Technology Could Make Lumina a Class-Defining Dermal Filler

LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, announced positive six-month interim results from its clinical trial of Lumina, a dermal filler.

ELEVAI LABS to Unveil PREx (Precision Regenerative Exosome Technology) at ASLMS Annual Meeting

ELEVAI LABS to Unveil PREx (Precision Regenerative Exosome Technology) at ASLMS Annual Meeting

PREx, ELEVAI's technology platform, utilizes the power of exosome, nanoparticle compartments that contain growth factors, to optimize the appearance of skin and improve the patient experience.

Overhead shot of dropper vitamin application on bald scalp, isolated on a clean background, well-lit studio setting, emphasizing effective hair care

Regenerative Hair Loss Treatment Targets Dormant Follicle Stem Cells [Clinical Trial]

Pelage Pharmaceuticals announced the commencement of the Phase 2a trial for PP405, a novel hair loss treatment targeting dormant follicle stem cells.

Turn Biotechnologies is currently developing mRNA medicines to cure untreatable, age-related conditions.

Preliminary Data Proves Turn Biotechnologies' Regenerative Therapies First Ever to Reverse Aging in Human Skin

Cell rejuvenation company, Turn Biotechnologies, released preliminary data that proves its therapies rejuvenate stem cells more effectively and safely compared to existing treatments.

3D Printed Breast implant consisting of 200cc in volume of CollPlant’s rhCollagen-based bioinks produced on a Stratasys’ Origin® printer

3D Bioprinted Regenerative Breast Implants Will Soon Become a Reality [Pre-Clinical Study]

The pre-clinical study is commencing for CollPlant's 3D printed breast implants (200cc volume) produced on a Stratasys' Origin printer.

Hydrinity Accelerated Skin Science Launches Supercharged Hyaluronic Acid Skin Care Line

Hydrinity's Supercharged HA & PPM6 Skin Care Line Features Regenerative Skin Repair & Anti-Aging Technology

Hydrinity Accelerated Skin Science announced the launch of a new facial skin care line that features supercharged hyaluronic acid and PPM6 technology; 6 powerful peptides and antioxidants that deliver skin-transforming results.

CollPlant Expands Bioink Platform with Launch of Collink.3D 90

Regenerative Breast Implants Could Soon Be a Reality as CollPlant Launches a Second BioInk, Collink.3D 90

Collink.3D 90 is complementary to CollPlant's first commercial bioink, Collink.3D 50, which was launched late 2021, offering increased mechanical properties to address additional printing requirements of soft and hard tissues.

Kosé describes iPS cells as a 'stem cell that can proliferate almost indefinitely and differentiate into any type of cell in the various tissues and organs, making them promising for regenerative medicine applications.'

Kosé is Developing Personalized Skin Care Using Consumers' Own iPS Cells

The initiative supports the rise of regenerative, longevity-focused beauty.

Dr. Nadav Orr, CollPlant’s VP R&D

CollPlant To Present on Collagen BioInk for 3D Bioprinting of Tissues

CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing.

Xylyx Bio Matrikynes Exhibits Clinical Anti-aging, Barrier Repair Efficacy

The ingredient is based on matrikines, whose intrinsic bioactivity have been shown to activate regenerative mechanisms that can drive tissue repair, the company reports.

Page 1 of 5